Timothy Gilligan, MD

216.444.6833

Timothy Gilligan, MD

Appointed: 2005

Timothy Gilligan, MD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.444.0391
WorkFax:216.444.9464
Timothy Gilligan, MD
Department: Urology
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.444.0391
WorkFax:216.444.9464
Timothy Gilligan, MD
Department: Center for Ethics, Humanities and Spiritual Care
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.444.0391
WorkFax:216.444.9464
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Timothy Gilligan, MD, is a Medical Oncologist at Cleveland Clinic's main campus in Cleveland, Ohio. He is board-certified in medical oncology and specializes in cancers of the testicles, bladder, prostate and kidneys as well as in problems related to cancer survivorship. Dr. Gilligan is co-Director of the Cleveland Clinic Center for Excellence in Healthcare Communication where he teaches communication skills, trains others to teach communication skills and provides physician coaching. He serves as Program Director of the Cleveland Clinic's Hematology-Oncology Fellowship and medical director of the inpatient solid tumor oncology service. Dr. Gilligan has published numerous original scientific articles in peer-reviewed journals, has written dozens of review articles and book chapters and has given dozens of lectures on genitourinary cancers and biomedical ethics. He has written and edited treatment guidelines and cancer-information summaries for national and international organizations, including the National Cancer Institute, the American Society of Clinical Oncology and UpToDate.

Professional Highlights

  • Member, The National Cancer Institute's Adult Treatment Editorial Board
  • Specialty Editor for Testicular Cancer and Penile Cancer, American Society for Clinical Oncology's People Living With Cancer program
  • Member, American Society of Clinical Oncology Quality of Care Committee
  • Chair, American Society of Clinical Oncology Quality of Care Committee Subcommittee on Measures of Quality
  • Chair, American Society of Clinical Oncology Test Materials Development Committee
  • Editorial Board member, The Oncologist

Education & Fellowships

Fellowship - Dana-Farber Cancer Institute Harvard Medical School
Medical Oncology
Boston, MA USA
2001
Residency - Brigham & Women's Hospital
Internal Medicine
Boston, MA
1999
Internship - Brigham & Women's Hospital
Internal Medicine
Boston, MA
1997
Medical School - Stanford University School of Medicine
Stanford, CA USA
1996
Graduate - Columbia University
New York, NY USA
1987
Undergraduate - Swarthmore College
Swarthmore, PA USA
1986

Certifications

  • Internal Medicine- Medical Oncology

Specialty Interests

Testicular cancer, bladder cancer, prostate cancer, kidney cancer, germ cell tumors, cancer survivorship, health disparities, prostate cancer in black men, health education, seminomas

Memberships

  • American Society of Clinical Oncology
  • American Academy on Communication in Healthcare

Treatment & Services

  • Clinical Trials

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Gilligan's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

Languages Spoken

  • English
Cleveland Clinic Mobile Site